GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Neurotech International Ltd (ASX:NTI) » Definitions » Retained Earnings

Neurotech International (ASX:NTI) Retained Earnings : A$-37.22 Mil (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Neurotech International Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Neurotech International's retained earnings for the quarter that ended in Dec. 2023 was A$-37.22 Mil.

Neurotech International's quarterly retained earnings declined from Dec. 2022 (A$-32.24 Mil) to Jun. 2023 (A$-36.43 Mil) and declined from Jun. 2023 (A$-36.43 Mil) to Dec. 2023 (A$-37.22 Mil).

Neurotech International's annual retained earnings declined from Jun. 2021 (A$-25.33 Mil) to Jun. 2022 (A$-28.70 Mil) and declined from Jun. 2022 (A$-28.70 Mil) to Jun. 2023 (A$-36.43 Mil).


Neurotech International Retained Earnings Historical Data

The historical data trend for Neurotech International's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neurotech International Retained Earnings Chart

Neurotech International Annual Data
Trend Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Retained Earnings
Get a 7-Day Free Trial -16.18 -17.90 -25.33 -28.70 -36.43

Neurotech International Semi-Annual Data
Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -27.15 -28.70 -32.24 -36.43 -37.22

Neurotech International Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.


Neurotech International  (ASX:NTI) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Neurotech International (ASX:NTI) Business Description

Traded in Other Exchanges
N/A
Address
145 Stirling Highway, Suite 5 CPC, Nedlands, WA, AUS, 6009
Neurotech International Ltd is a medical device and solutions company. It researches, designs, markets, and produces wearable neurotechnology devices to assist with neurological conditions such as autism. Geographically, all the business activities of the firm function through the region of Australia. It operates in one segment named Medical Device Development and Distribution.

Neurotech International (ASX:NTI) Headlines

From GuruFocus

13 Stocks With Dividend Yields Over 10%

By Dividend Dividend 11-12-2014

20 Stocks with Yields over 10% and Highest Buy Ratings

By Dividend Dividend 01-17-2013

How to Capitalize on the Bakken Oil Boom

By Vitaliy Katsenelson Vitaliy Katsenelson 11-09-2013

9 Stocks With Yields Over 10% And Buy Or Better Rating

By Dividend Dividend 08-17-2013